Protalix BioTherapeutics, Inc.

PLX · NYSE · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.2B · 226 employees
492
SEC Filings
$2.72
Close 2026-09-25
226
Employees

Business Summary

Protalix BioTherapeutics is a commercial-stage biopharmaceutical company focused on discovery, development, production, and commercialization of therapeutics for rare diseases. It uses its proprietary ProCellEx plant cell-based protein expression system. Its approved products include Elelyso (taliglucerase alfa) for Gaucher disease and Elfabrio (pegunigalsidase alfa) for Fabry disease. Pipeline candidates include PRX-115 for uncontrolled gout and PRX-119 for NETs-related diseases.

Latest Stock Quote

PLX 2026-09-25 $2.72 O:$2.76 H:$2.775 L:$2.7 Vol:0.4M VWAP:$2.7239
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-21

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-182025-12-310001104659-26-029858EDGAR68K words
2025-03-172024-12-310001558370-25-003039EDGAR69K words
2024-03-142023-12-310001558370-24-003161EDGAR73K words
2023-02-272022-12-310001558370-23-002102EDGAR70K words
2022-03-312021-12-310001558370-22-004823EDGAR—
2021-03-302020-12-310001558370-21-003681EDGAR—
2020-03-122019-12-310001104659-20-032540EDGAR—
2019-03-182018-12-310001144204-19-014464EDGAR—
2018-03-062017-12-310001144204-18-013053EDGAR—
2017-03-162016-12-310001144204-17-015083EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-122026-06-300001104659-26-094444EDGAR17K words
2025-11-132025-09-300001104659-25-110824EDGAR22K words
2025-08-142025-06-300001558370-25-011471EDGAR21K words
2025-05-092025-03-310001558370-25-007063EDGAR19K words
2024-11-142024-09-300001558370-24-015612EDGAR23K words
2024-08-142024-06-300001558370-24-012134EDGAR23K words
2024-05-102024-03-310001558370-24-007695EDGAR21K words
2023-11-062023-09-300001558370-23-017664EDGAR25K words
2023-08-072023-06-300001558370-23-013483EDGAR23K words
2023-05-042023-03-310001558370-23-008132EDGAR20K words
2022-11-142022-09-300001558370-22-017554EDGAR—
2022-08-152022-06-300001558370-22-013560EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-120001104659-26-094433EDGAR4K words
2026-03-180001104659-26-029846EDGAR4K words
2026-03-090001104659-26-024975EDGAR2K words
2026-02-110001104659-26-013498EDGAR3K words
2026-01-300001104659-26-008410EDGAR2K words
2026-01-050001104659-26-000393EDGAR2K words
2025-11-130001104659-25-110821EDGAR4K words
2025-11-030001104659-25-105594EDGAR2K words
2025-10-170001104659-25-100264EDGAR3K words
2025-08-220001104659-25-081924EDGAR1K words

492 total filings indexed. 460 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

rare-diseases orphan-diseases gaucher-disease-treatment fabry-disease-treatment uncontrolled-gout-treatment nets-related-diseases renal-diseases plant-cell-based-protein-expression-(procellex) pegylation

Company Identity

CIK0001006281
TickerPLX
ExchangeNYSE
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.protalix.com
Listed1996-01-02

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 4682524a5c6c5f97a21a66d78da11b978bfb0798e4adecbac2b86819ffc57b50
parent: d5578334b47b3f9fb8955499aba41a11ac448d3a0a5fcdaa05248ccd72e70096
content hash: bbee8aae606239457be428d00c28fb5bb5af4b1a9a689e67b6fd73298e85e853
signed: 2026-09-29T12:02:42.763Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up PLX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on PLX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/PLX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.